IDEXX LABORATORIES INC /DE Quarterly Liabilities and Equity in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Idexx Laboratories Inc /De quarterly Liabilities and Equity history and growth rate from Q2 2010 to Q3 2024.
  • Idexx Laboratories Inc /De Liabilities and Equity for the quarter ending September 30, 2024 was $3.35B, a 8.57% increase year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $3.35B +$264M +8.57% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $3.41B +$544M +19% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $3.35B +$545M +19.4% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $3.26B +$513M +18.7% Dec 31, 2023 10-Q 2024-10-31
Q3 2023 $3.09B +$446M +16.9% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $2.87B +$264M +10.1% Jun 30, 2023 10-Q 2023-08-01
Q1 2023 $2.81B +$216M +8.32% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 $2.75B +$310M +12.7% Dec 31, 2022 10-K 2024-02-22
Q3 2022 $2.64B +$254M +10.7% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 $2.61B +$195M +8.09% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $2.59B +$265M +11.4% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $2.44B +$143M +6.22% Dec 31, 2021 10-K 2023-02-16
Q3 2021 $2.39B +$338M +16.5% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $2.41B +$451M +23% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $2.33B +$441M +23.4% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $2.29B +$462M +25.2% Dec 31, 2020 10-K 2022-02-16
Q3 2020 $2.05B +$296M +16.9% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 $1.96B +$236M +13.7% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $1.89B +$205M +12.2% Mar 31, 2020 10-Q 2020-04-30
Q4 2019 $1.83B +$295M +19.2% Dec 31, 2019 10-K 2021-02-12
Q3 2019 $1.75B +$207M +13.4% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $1.72B +$204M +13.4% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $1.68B +$211M +14.4% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $1.54B -$176M -10.3% Dec 31, 2018 10-K 2020-02-14
Q3 2018 $1.54B -$125M -7.48% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 $1.52B -$116M -7.11% Jun 30, 2018 10-Q 2018-08-01
Q1 2018 $1.47B -$103M -6.53% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 $1.71B +$183M +11.9% Dec 31, 2017 10-K 2019-02-15
Q3 2017 $1.67B +$169M +11.3% Sep 30, 2017 10-Q 2017-10-31
Q2 2017 $1.64B +$148M +9.93% Jun 30, 2017 10-Q 2017-08-01
Q1 2017 $1.57B +$93.4M +6.32% Mar 31, 2017 10-Q 2017-04-28
Q4 2016 $1.53B +$55.7M +3.78% Dec 31, 2016 10-K 2018-02-16
Q3 2016 $1.5B +$23.2M +1.57% Sep 30, 2016 10-Q 2016-11-01
Q2 2016 $1.49B +$11.9M +0.8% Jun 30, 2016 10-Q 2016-08-02
Q1 2016 $1.48B +$47.6M +3.33% Mar 31, 2016 10-Q 2016-04-29
Q4 2015 $1.47B +$90.8M +6.56% Dec 31, 2015 10-K 2017-02-17
Q3 2015 $1.48B +$187M +14.5% Sep 30, 2015 10-Q 2015-10-28
Q2 2015 $1.48B +$194M +15.1% Jun 30, 2015 10-Q 2015-07-30
Q1 2015 $1.43B +$169M +13.4% Mar 31, 2015 10-Q 2015-04-28
Q4 2014 $1.38B +$154M +12.5% Dec 31, 2014 10-K 2016-02-17
Q3 2014 $1.29B +$95.4M +7.98% Sep 30, 2014 10-Q 2014-10-24
Q2 2014 $1.28B +$119M +10.2% Jun 30, 2014 10-Q 2014-07-25
Q1 2014 $1.26B +$130M +11.5% Mar 31, 2014 10-Q 2014-04-25
Q4 2013 $1.23B +$127M +11.5% Dec 31, 2013 10-K 2015-02-17
Q3 2013 $1.2B +$102M +9.32% Sep 30, 2013 10-Q 2013-10-22
Q2 2013 $1.16B +$96.8M +9.07% Jun 30, 2013 10-Q 2013-07-23
Q1 2013 $1.13B +$71.5M +6.74% Mar 31, 2013 10-Q 2013-04-23
Q4 2012 $1.1B +$72.8M +7.06% Dec 31, 2012 10-K 2014-02-18
Q3 2012 $1.09B +$124M +12.8% Sep 30, 2012 10-Q 2012-10-19
Q2 2012 $1.07B +$117M +12.3% Jun 30, 2012 10-Q 2012-07-20
Q1 2012 $1.06B +$152M +16.7% Mar 31, 2012 10-Q 2012-04-20
Q4 2011 $1.03B +$134M +14.9% Dec 31, 2011 10-K 2013-02-19
Q3 2011 $969M +$107M +12.4% Sep 30, 2011 10-Q 2011-10-21
Q2 2011 $951M +$117M +14% Jun 30, 2011 10-Q 2011-07-22
Q1 2011 $909M Mar 31, 2011 10-Q 2011-04-21
Q4 2010 $897M Dec 31, 2010 10-K 2012-02-17
Q3 2010 $862M Sep 30, 2010 10-Q 2010-10-22
Q2 2010 $834M Jun 30, 2010 10-Q 2010-07-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.